Catalyst Wire Dossier Catalyst Wire Dossier

UMECLIDINIUM AND VILANTEROL ELLIPTA

umeclidinium bromide and vilanterol triflate · Prasco Laboratories
Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for UMECLIDINIUM AND VILANTEROL ELLIPTA, covering 2013-12-18 to 2023-06-02. Get the full timeline:

Most recent: FDA Approved: UMECLIDINIUM AND VILANTEROL ELLIPTA — Supplemental Application (Prasco Laboratories)

See pricing